Mode
Text Size
Log in / Sign up

TMS targeting the ventral attention network may address heterogeneity in alcohol use disorder with depressionNew target for brain stimulation in alcohol and depression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that targeting the ventral attention network may provide a more precise mechanism for treating alcohol use disorder with MDD.

This mini review examines the application of transcranial magnetic stimulation (TMS) for patients with alcohol use disorder (AUD) and comorbid major depressive disorder (MDD). The authors focus on targeting the ventral attention network (VAN), specifically the temporoparietal junction, as a means to address current clinical challenges.

The synthesis highlights that existing TMS paradigms are often region-centric and suffer from significant methodological heterogeneity. Consequently, there is uncertainty regarding optimal targets and mechanisms of action for AUD populations. The authors propose the temporoparietal junction as a theoretically grounded and neuromodulation-accessible entry point for probing VAN responsivity to improve outcomes in these patients.

Limitations include the high degree of methodological heterogeneity across current studies and uncertainties regarding specific mechanisms of action. The review does not report clinical trial data but rather proposes a theoretical framework. This work provides a foundation for developing more precise, biologically grounded approaches to address relapse vulnerability by reframing TMS as a probe of network dynamics.

How this fits prior evidence

This mini review addresses gaps in current treatment strategies for alcohol use disorder and comorbid depression. While previous evidence highlights the role of neuronavigation and connectivity guided targeting in rTMS to potentially improve outcomes in bipolar disorder, this review focuses on the specific theoretical framework of targeting the ventral attention network (VAN) via the temporoparietal junction to address heterogeneity in AUD.

Living with both a drinking problem and depression is incredibly hard. Current treatments often struggle to address how these two conditions interact in the brain. Because of this, researchers are looking for better ways to target the specific brain networks that control focus and emotional responses.

One promising area is the ventral attention network. Specifically, scientists are looking at a spot called the temporoparietal junction. This area acts as an entry point to study how the brain processes important information. By focusing on this specific network instead of just one isolated spot, doctors hope to create more precise ways to treat patients.

It is important to note that this research is currently a theoretical framework rather than a report from a clinical trial. While it offers a promising path toward better treatment for relapse and mood regulation, the exact best targets and mechanisms are still being studied.

What this means for you:
Targeting the ventral attention network may offer a more precise way to treat alcohol use disorder and depression.

Common questions

What is the goal of targeting the ventral attention network?

The goal is to move away from just targeting one spot in the brain. By focusing on the ventral attention network, specifically the temporoparietal junction, researchers hope to better address how patients manage focus and emotions. This could help create more precise treatments for people dealing with both alcohol use disorder and depression.

Is this a new treatment that can be used immediately?

Not yet. This research provides a theoretical framework rather than results from a clinical trial. It identifies a promising area for future study to help address the different ways patients experience symptoms and the risk of relapse, but it is not a currently available medical treatment.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Alcohol use disorder (AUD) is frequently complicated by co-occurring major depressive disorder (MDD), a comorbidity associated with greater clinical severity, elevated relapse risk, and poorer treatment outcomes than either condition alone. Despite the prevalence and burden of this dual diagnosis, interventions that simultaneously address alcohol use and depressive symptoms show limited effectiveness. Converging evidence from neuroimaging and translational research indicates that AUD and MDD share disruptions across large-scale brain networks involved in salience processing, attentional control, and affect regulation. In this Mini Review, we synthesize the literature on transcranial magnetic stimulation (TMS) in AUD, highlighting dominant region-centric paradigms (including those adapted from major depressive disorder), methodological heterogeneity, and ongoing uncertainties regarding optimal targets and mechanisms of action. We then outline a network-based framework centered on the ventral attention network (VAN) as an alternative neuromodulation approach for AUD with co-occurring MDD. Drawing on attention neuroscience and systems-level models of addiction, we emphasize the temporoparietal junction as a theoretically grounded and neuromodulation-accessible entry point for probing VAN responsivity and plasticity. By reframing TMS as a mechanistic probe of network dynamics rather than solely as a therapeutic intervention, this perspective provides a foundation for developing more precise, biologically grounded approaches to addressing heterogeneity and relapse vulnerability in this clinically complex population.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.